Merck (XTER:6MK) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:6MK Merck & Co Inc XTER:6MK
75 GF Score
Price €110.76
GF Value €103.72
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Merck Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

XTER:6MK
75GF Score
Merck & Co Inc XTER:6MK
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (XTER:6MK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of €110.76 is trading 6.8% above its estimated GF Value™ of €103.72. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for XTER:6MK:

  • Dividends Received:
  • GF Value™: €103.72 vs. price of €110.76 (6.8% above fair value)
  • GF Score™: 75/100 with 8 warning signs

No single metric tells the full story. See the XTER:6MK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
75GF Score

Get the complete analysis for XTER:6MK

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€110.76
Price
€103.72
GF Value